Nutraceutical support in heart failure: a position paper of the International Lipid Expert Panel (ILEP).
Level 5 - mechanism / opinion, no new human data
Expert panel position paper and consensus statement reviewing clinical literature
PubMed 32172721 · doi:10.1017/S0954422420000049
What was done
The International Lipid Expert Panel (ILEP) conducted a PubMed search from January 1970 to June 2019 covering terms related to nutraceuticals, dietary supplements, herbal drugs, heart failure, and left ventricular dysfunction. An expert panel reviewed available clinical evidence, synthesized findings on phytochemicals and nutraceuticals for heart failure prevention and adjunct management, and assigned recommendation levels using predefined grading scales.
What was found
The abstract reports no numerical data, pooled effect sizes, or statistical metrics. It qualitatively reports that trials of hawthorn, coenzyme Q10, l-carnitine, d-ribose, carnosine, vitamin D, probiotics, n-3 polyunsaturated fatty acids, and beet nitrates were associated with improvements in self-perceived quality of life and cardiac functional measures (left ventricular ejection fraction, stroke volume, and cardiac output) with minimal or no reported adverse effects. Benefits were noted to be greater in earlier stages of heart failure.
Why it matters
It provides expert consensus guidance on which dietary supplements have clinical trial support as adjuncts to standard medical therapy for heart failure, particularly for patients with suboptimal medical optimization or low adherence.
Limits
The abstract provides no quantitative data, sample sizes, study counts, or formal meta-analytic pooling. As a consensus statement, it reflects expert interpretation and narrative synthesis rather than a standardized systematic review. Long-term hard clinical outcomes, such as all-cause mortality and heart failure hospitalization rates, are not quantified in the abstract.
Cited by
- partial Administering a metabolic supplement cocktail including CoQ10, carnitine, creatine, ribose, alpha-lipoic acid, N-acetylcysteine, and B vitamins improves ejection fraction in heart failure patients.